Luspatercept Injection [Reblozyl] Clinical Trials
2 recruitingDrug
Phase 22Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA
MDSMyelodysplastic Syndromes
Groupe Francophone des Myelodysplasies150 enrolled40 locationsNCT05181735
Recruiting
Phase 2
Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD
Myelodysplastic SyndromesAnemiaTransfusion-dependent Anemia+1 more
Associazione Qol-one22 enrolled23 locationsNCT05924100